Foam Granulation - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Foam Granulation
The authors review developments in wet granulation using a twin-screw extruder.


Pharmaceutical Technology
Volume 37, Issue 3, pp. 68-72

References

1. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Drug Dev. Ind. Pharm. 30 (6) 679-691 (2004).

2. L. Tan, A.J. Carella, Y. Ren, and J.B. Lo, Pharm. Dev. Tech. 16 (4) 302-315 (2011).

3. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 239 (1-2) 69-80 (2002).

4. E.I. Keleb, A. Vermeire, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 273 (1-2) 183-194 (2004).

5. D. Djuric and P. Kleinebudde, J. Pharm. Sci. 97 (11) 4934-4942 (2008).

6. M.R. Thompson, S. Weatherley, R.N. Pukadyil, and P.J. Sheskey, Drug Dev. Ind. Pharm. 38 (7) 771-784 (2012).

7. W. Thiele, "Twin-Screw Extrusion and Screw Design," in Pharmaceutical Extrusion Technology, I. Ghebre-Sellassie and C. Martin, Eds. (Marcel Dekker, New York, NY, 2003), pp. 69-98.

8. D. Djuric, et al., Eur. J. Pharm. Biopharm. 71 (1) 155-160 (2009).

9. M.R. Thompson and J. Sun, J. Pharm. Sci. 99 (4) 2090-2103 (2010).

10. R.M. Dhenge, et al., Pow. Tech., DOI: 10.1016/j.powtec.2012.05.045, May 29, 2012.

11. U. Shah, Pharm. Tech. 29 (6) 52-66 (2005).

12. B. Van Melkebeke, C. Vervaet, and J.P. Remon, Inter. J. Pharm. 356 (1-2) 224-230 (2008).

13. N.O. Lindberg, C. Tufvesson, P. Holm, and L. Olbjer, Drug Dev. Ind. Pharm. 14 (13) 1791-1798 (1988).

14. M.R. Thompson, B. Mu, and P.J. Sheskey, Pow. Tech., 228, 339-348 (2012).

15. C.M. Keary and P.J. Sheskey, Drug Dev. Ind. Pharm., 30 (8) 831-845 (2004).

16. M.X.L. Tan, L.S. Wong, K.H. Lum, and K.P. Hapgood, Chem. Eng. Sci., 64 (12) 2826-2836 (2009).

17. M.X.L. Tan and K.P. Hapgood, Pow. Tech., 218, 149-156 (2012).

18. S.L. Cantor, S. Kothari, and O.M.Y. Koo, Pow. Tech., 195, 15-24 (2009).

19. P. Sheskey, C. Keary, D. Clark, and K. Balwinski, Pharm. Tech., 31 (4) 94-108 (2007).

20. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Res. Des. 89 (5) 526-536 (2011).

21. M.X.L. Tan and K.P. Hapgood, Chem. Eng. Sci. 66 (21) 5204-5211 (2011).

Michael R. Thompson* is an associate professor in the Department of Chemical Engineering at McMaster University, Hamilton, Ontario, L8S 4L7, Canada, Tel: 905.525.9140,
, and Paul J. Sheskey is a principal research scientist at Larkin Laboratory, The Dow Chemical Company, Midland, Michigan.

*To whom all correspondence should be addressed.

Submitted: Sept. 6, 2012. Accepted: Sept. 28, 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
27%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
8%
All of the above.
41%
No government involvement in patient treatment or drug development.
11%
Jim Miller Outsourcing Outlook Jim MillerCMO Industry Thins Out
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerFluorination Remains Key Challenge in API Synthesis
Marilyn E. Morris Guest EditorialMarilyn E. MorrisBolstering Graduate Education and Research Programs
Jill Wechsler Regulatory Watch Jill Wechsler Biopharma Manufacturers Respond to Ebola Crisis
Sean Milmo European Regulatory WatchSean MilmoHarmonizing Marketing Approval of Generic Drugs in Europe
FDA Reorganization to Promote Drug Quality
FDA Readies Quality Metrics Measures
New FDA Team to Spur Modern Drug Manufacturing
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Source: Pharmaceutical Technology,
Click here